Please note that the contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.
For Investors Relations news and news releases from Fujifilm and FUJIFILM Business Innovation for 2019 and before, please click：
- Sep 2, 2021
- Fujifilm launches FUJINON Lens XF33mmF1.4 R LM WR (Fujifilm)
- Sep 2, 2021
- Fujifilm unveils the latest development roadmap for interchangeable lenses for the X Series of mirrorless digital cameras (Fujifilm)
- Sep 2, 2021
- Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream (Fujifilm)
- Aug 31, 2021
- Launch of Therapeutic Radiopharmaceutical Product, Lutathera® Injection targeting neuroendocrine tumors in Japan (FUJIFILM Toyama Chemical)
- Aug 24, 2021
- FUJIFILM Business Innovation Asia Pacific Brings Affordable Web-to-Print Solution to Businesses with Aleyant Software Services (FUJIFILM Business Innovation)
- Jul 27, 2021
- FUJIFILM Business Innovation Launches New Brand for Production Printers (FUJIFILM Business Innovation)
- Jul 6, 2021
- FUJIFILM Holdings adopts a “DX Vision”
- Jun 30, 2021
- FUJIFILM Business Innovation Announces Management Changes (FUJIFILM Business Innovation)
- Jun 29, 2021
- $850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity (Fujifilm)
- Jun 23, 2021
-
Marketing Authorization Granted for Lutathera® Injection in Japan
- The first approval in Japan for peptide receptor radionuclide treatment drug, providing a new therapeutic option for neuroendocrine tumors (FUJIFILM Toyama Chemical) - May 27, 2021
- FUJIFILM Wako Pure Chemical launches “E484Q mutation detection kit” reagent for detecting a SARS-CoV-2 mutation (FUJIFILM Wako Pure Chemical)
- May 18, 2021
- BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases (Fujifilm)
- May 17, 2021
- FUJIFILM Wako Pure Chemical launches mutation detection kit for SARS-CoV-2 “L452R” (FUJIFILM Wako Pure Chemical)